Skip to main content

CombiMatrix Molecular Diagnostics Receives CLIA Certification

NEW YORK, March 31 (GenomeWeb News) - CombiMatrix Molecular Diagnostics has received CLIA certification to operate as a clinical laboratory, the company announced today.

 

Matt Watson, CEO of CMDX, said his company had been working to establish processes and procedures that would meet CLIA's quality control and quality assurance standards since it opened in May 2005.

 

CMDX is a wholly owned subsidiary of CombiMatrix, which is a unit of Acacia Research.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.